KaydedilenlerDerginizi ekleyin

Dergiler / The Anatolian Journal of Cardiology / 2019 / Cilt: 21 - Sayı: 4

Management of prosthetic valve thrombosis concomitant with coronary embolism

Macit KALÇIK
Ahmet GÜNER
Sabahattin GÜNDÜZ
Mehmet ÖZKAN
Sayfa
238–239
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

On the other hand, we believe that there are severalmajor drawbacks that need to be addressed.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:We have recently read with great interest the article by Olcay(1) published in Anatol J Cardiol 2018; 20: 365-7.
📊
Temel Bulgular & Veri:We appreciatethe author for his report describing the concomitant left maincoronary artery and mitral prosthetic valve thrombosis (PVT)treatment.
💡
Sonuç & Katkı:On the other hand, we believe that there are severalmajor drawbacks that need to be addressed.
🔬Tür:Araştırma Makalesi
📍Kapsam:2018 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

We have recently read with great interest the article by Olcay(1) published in Anatol J Cardiol 2018; 20: 365-7. We appreciatethe author for his report describing the concomitant left maincoronary artery and mitral prosthetic valve thrombosis (PVT)treatment. On the other hand, we believe that there are severalmajor drawbacks that need to be addressed.

🔖

Bu Makaleye Atıf Yap

KALÇIK, M., GÜNER, A., GÜNDÜZ, S., ÖZKAN, M. (2019). Management of prosthetic valve thrombosis concomitant with coronary embolism. The Anatolian Journal of Cardiology, Cilt: 21 - Sayı: 4, 238–239. https://ajindex.com/articles/367220

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (7)

  1. Olcay A. Concomitant left main coronary artery and prosthetic mitral valve thrombosis treatment. Anatol J Cardiol 2018; 20: 365-7
  2. Guner A, Kılıcgedik A, Kalçık M, Ozkan M. ST-segment elevation myocardial infarction possibly caused by thromboembolism from left atrial appendage thrombus after incomplete surgical ligation. Echocardiography 2018; 35: 1889-92
  3. Yesin M, Karakoyun S, Kalçık M, Gürsoy MO, Gündüz S, Astarcıoğlu MA, et al. Status of the Epicardial Coronary Arteries in Non-ST Elevation Acute Coronary Syndrome in Patients with Mechanical Prosthetic Heart Valves (from the TROIA-ACS Trial). Am J Cardiol 2018; 122: 638-44
  4. Guner A, Kalcik M, Gursoy MO, Gunduz S, Ozkan M. How to perform and manage low-dose and slow/ultra-slow tissue type plasminogen activator infusion regimens in patients with prosthetic valve thrombosis. J Thromb Thrombolysis 2018; 46: 399-402
  5. Özkan M, Gündüz S, Gürsoy OM, Karakoyun S, Astarcıoğlu MA, Kalçık M, et al. Ultraslow thrombolytic therapy: A novel strategy in the management of PROsthetic MEchanical valve Thrombosis and the prEdictors of outcomE: The Ultra-slow PROMETEE trial. Am Heart J 2015; 170: 409-18
  6. Özkan M, Gündüz S, Biteker M, Astarcioglu MA, Çevik C, Kaynak E, et al. Comparison of different TEE-guided thrombolytic regimens for prosthetic valve thrombosis: the TROIA trial. JACC Cardiovasc Imaging 2013; 6: 206-16
  7. Gürsoy MO, Kalçık M, Yesin M, Karakoyun S, Bayam E, Gündüz S, et al. A global perspective on mechanical prosthetic heart valve thrombosis: Diagnostic and therapeutic challenges. Anatol J Cardiol 2016; 16: 980-9.